Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Blinded, Placebo Controlled, Safety and Pharmacodynamic Study of BHT-3021 With Open Label Cross-Over in Subjects With Type I Diabetes Mellitus

NCT00453375 is registered in ClinicalTrials.gov with Bayhill Therapeutics as lead sponsor.

NCT NCT00453375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00453375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Blinded, Placebo Controlled, Safety and Pharmacodynamic Study of BHT-3021 With Open Label Cross-Over in Subjects With Type I Diabetes Mellitus
Lead sponsor
Bayhill Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2006
Completion date
May 31, 2011
Enrollment
80 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, hypoglycemia